Open Access

Biological effects and clinical characteristics of microRNA‑106a in human colorectal cancer

  • Authors:
    • Yuzheng He
    • Guiqi Wang
    • Lei Zhang
    • Congjie Zhai
    • Jun Zhang
    • Xusheng Zhao
    • Xia Jiang
    • Zengren Zhao
  • View Affiliations

  • Published online on: May 16, 2017     https://doi.org/10.3892/ol.2017.6179
  • Pages: 830-836
  • Copyright: © He et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

MicroRNAs serve important roles in various diseases, particularly cancer. microRNA‑106a (miR‑106a) exhibits abnormal expression and oncogenic activity in carcinogenesis. The clinical significance of the abnormal expression of miR‑106a in colorectal cancer is poorly understood. In the present study, miR‑106a expression from colorectal cancer tissues was quantified using the reverse transcription‑quantitative polymerase chain reaction. The overexpression or knockdown of miR‑106a was performed by transfection with microRNA mimic or inhibitor in human colorectal carcinoma HCT116 cells. The overexpression of miR‑106a promoted viability and inhibited apoptosis in colorectal cancer cells. The association between miR‑106a expression and clinicopathological factors was analyzed, and it was identified that miR‑106a exhibited significantly increased expression in adenocarcinoma tissues compared with in mucinous carcinoma tissues, and the expression of miR‑106a was identified to be associated with the depth of invasion and differentiation. The expression of miR‑106a in plasma was also determined and it was identified that increased expression of miR‑106a, as a characteristic of patients with colorectal cancer, may be distinguished from that of other patients by digitization of the areas under the receiver operating characteristic curves. These data suggested that miR‑106a is a potential biomarker in the diagnosis of colorectal carcinoma. However, the underlying molecular mechanism of miR‑106a‑promoted viability and inhibition of apoptosis requires further investigation.
View Figures
View References

Related Articles

Journal Cover

July-2017
Volume 14 Issue 1

Print ISSN: 1792-1074
Online ISSN:1792-1082

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
He Y, Wang G, Zhang L, Zhai C, Zhang J, Zhao X, Jiang X and Zhao Z: Biological effects and clinical characteristics of microRNA‑106a in human colorectal cancer. Oncol Lett 14: 830-836, 2017
APA
He, Y., Wang, G., Zhang, L., Zhai, C., Zhang, J., Zhao, X. ... Zhao, Z. (2017). Biological effects and clinical characteristics of microRNA‑106a in human colorectal cancer. Oncology Letters, 14, 830-836. https://doi.org/10.3892/ol.2017.6179
MLA
He, Y., Wang, G., Zhang, L., Zhai, C., Zhang, J., Zhao, X., Jiang, X., Zhao, Z."Biological effects and clinical characteristics of microRNA‑106a in human colorectal cancer". Oncology Letters 14.1 (2017): 830-836.
Chicago
He, Y., Wang, G., Zhang, L., Zhai, C., Zhang, J., Zhao, X., Jiang, X., Zhao, Z."Biological effects and clinical characteristics of microRNA‑106a in human colorectal cancer". Oncology Letters 14, no. 1 (2017): 830-836. https://doi.org/10.3892/ol.2017.6179